ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage

Lihong Chen1, Daniele M Gilkes, Yu Pan

  • 1Molecular Oncology Program, H Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa, FL 33612, USA.

The EMBO Journal
|September 16, 2005
PubMed

Insights

DNA damage triggers ATM-dependent MDMX phosphorylation and degradation by MDM2, enhancing tumor suppressor p53 activation. This pathway is crucial for maintaining genomic stability and preventing cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • The p53 tumor suppressor is critical for genomic stability and cancer prevention, activated by DNA damage.
  • ATM kinase signaling and MDM2/MDMX proteins are key regulators of p53 response.
  • Understanding MDMX regulation is vital for cancer therapy development.

Purpose of the Study:

  • To investigate the role of ATM and Chk2 kinases in MDMX regulation following DNA damage.
  • To elucidate the mechanism by which MDMX is degraded and how this impacts p53 activation.
  • To identify specific phosphorylation sites on MDMX involved in its regulation.

Main Methods:

  • Mass spectrometry for phosphosite identification.
  • RNA interference (RNAi) to reduce MDMX levels.
  • Phosphopeptide-specific antibodies for site validation.
  • Site-directed mutagenesis to assess phosphorylation site function.
  • Western blotting to detect protein levels and modifications.

Main Results:

  • DNA damage induces ATM-dependent phosphorylation and MDM2-mediated degradation of MDMX.
  • Specific phosphorylation sites (S342, S367, S403) on MDMX were identified and confirmed.
  • Mutation of these sites confers resistance to MDM2-mediated degradation.
  • Chk2 kinase is required for MDMX phosphorylation at S342/S367 and subsequent degradation.
  • Reduced MDMX levels enhance p53 activation in response to DNA damage.

Conclusions:

  • ATM and Chk2 kinases orchestrate MDMX phosphorylation, targeting it for MDM2-mediated degradation after DNA damage.
  • This MDMX degradation is a critical step for p53 stabilization and activation, promoting genomic integrity.
  • The findings reveal a novel regulatory axis contributing to the DNA damage response and offer potential therapeutic targets.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...